Voglistat 0.3 Tab

Composition

Voglibose 0.3 mg

Uses of Voglistat 0.3 Tab

Management of type 2 diabetes mellitus (especially post‑prandial/high after-meal blood sugar) as an adjunct to diet and exercise; used alone or with other antidiabetic medicines.

• •Reduces post-meal blood sugar spikes
• •Improves glycaemic control with diet and exercise
• •Can be combined with other antidiabetic medicines
• •Non-insulin oral therapy option

How it works

Voglibose is an alpha‑glucosidase inhibitor that delays digestion and absorption of carbohydrates in the small intestine. This reduces the rise in blood glucose after meals and helps improve overall glycaemic control.

Directions for use

Tablet for oral use. Usually taken just before the start of each main meal (or with the first bite of food) as prescribed. If you skip a meal, skip the dose. Follow diet/exercise plan; monitor blood glucose regularly.

Side effects

Common side effects of Voglistat 0.3 Tab may include:

• •Flatulence
• •abdominal bloating
• •abdominal pain
• •diarrhoea
• •nausea

Warnings & precautions

May cause gastrointestinal side effects due to fermentation of undigested carbohydrates. Risk of hypoglycaemia increases when used with insulin or sulfonylureas—if low sugar occurs, treat with oral glucose (dextrose) rather than sucrose/table sugar. Use with caution in liver disease; periodic liver function monitoring may be advised. Avoid/use with caution in inflammatory bowel disease, intestinal obstruction, colonic ulceration, or chronic intestinal disorders. Not indicated for type 1 diabetes or diabetic ketoacidosis.